DSM BioSolutions, DSM’s microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics’ lead biobetter product, HiPEG IFN alpha-2a. Continue Reading
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner of the New Drug Application as well as FemmePharma, the listed owner of the patent, of its ANDA filing. KV is a licensee under the patent. Perrigo believes it is first-to-file on this product. Continue Reading
HemaQuest Pharmaceuticals, a clinical stage biotechnology company developing small molecule therapeutics for sickle cell disease, beta thalassemia and EBV-related cancers, announced today the closing of an additional $4M to its Series B financing by new investor, Latterell Venture Partners. This investment brings the total Series B financing to $16M. Continue Reading
MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced the expansion of its agreement with Midatech Group (Oxford, UK) to develop nanoparticle-based proteins and peptides for therapeutic delivery utilizing pharmaceutical films. Under the terms of the expanded agreement, MonoSol Rx has made an equity investment in Midatech and Keith Kendall, Executive Vice President and Chief Financial Officer of MonoSol Rx, will join the Midatech Board of Directors. Continue Reading
A US District Court judge in Texas yesterday ruled that it granted an injunction in favor of Smith & Nephew’s Endoscopy Division. As expected the Judge also granted Arthrex’s motion to stay the injunction pending an appeal of the judgment. Continue Reading
The Washington Post: “The health-care legislation signed into law in March provides a major boost to community health centers: $11 billion over five years. The first of these federally supported primary-care clinics opened in 1965.” The law also provides funding designed to increase the supply of primary-care providers. 和, “[o]n Wednesday, Secretary of Health and Human Services Kathleen Sebelius announced that the federal government will spend $250 million in programs to increase the number of doctors, nurses and other care providers. Continue Reading
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI), which will become effective prior to market open on Monday, 可能 24, 2010. Continue Reading
Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical products in China, said today that it has become the exclusive China distributor of Welch Allyn’s patient monitors. Continue Reading
OnCallData, whose pioneering electronic-prescribing product was the first electronic prescribing application to launch two-way connectivity with national pharmacy chains, announced this week that it has integrated its systems with ShareStream, a rich media platform that allows organizations to educate and train their workforces through multimedia while safeguarding and controlling access to content during online delivery through digital rights management, to provide online learning and secure, media-based communications within the OnCallData Community Health Portal. Continue Reading
National Health Investors, 公司. announced today that it will pay a second quarter dividend of 57.5 cents per common share to shareholders of record on June 30, 2010 and payable on August 10, 2010. Continue Reading
